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ABSTRAK 
Kesudahan pesakit akibat jangkitan paru-paru perolehan komuniti 
di·Hospital Universiti Sains Malaysia. 
Latar belakang: 
Penyakit jangkitan paru-paru perolehan komuniti masih merupakan penyebab 
utama kemasukan ke hospital. Hasil daripada beberapa keputusan kajian 
yang telah dibuat, kadar kematian yang dialami oleh pesakit di hospital adalah 
tinggi. Kadar kematian ini dipengaruhi oleh sebilangan faktor-faktor kllinikal 
semasa kemasukan ke hospital. Walaubagaimanapun, kajian terhadap kadar 
kematian dan faktor-faktor yang mempengaruhinya masih sedikit. Tujuan 
utama kajian ini adalah untuk menilai kadar kematian akibat jangkitan paru-
paru perolehan komuniti di Hospital Universiti Sains Malaysia dan mengenal 
pasti faktor yang mempengaruhi kadar kematian. 
Metodologi: 
lni merupakan kajian retrospektif yang dilakukan dari Januari 2004 hingga 
Disember 2004. Semua rekod pesakit jangkitan paru-paru perolehan 
komuniti disemak. Data-data pesakit yang memenuhi syarat-syarat kajian 
direkodkan. Maklumat yang diambil adalah data demografi, penemuan 
klinikal, hasil keputusan penyiasatan makmal dan jenis rawatan antibiotik. 
Analisa terhadap data ini dilakukan untuk menilai kadar kematian dan 
xi 
seterusnya dianalisa untuk menentukan kaitannya dengan kematian akibat 
jangkitan paru-paru perolehan komuniti. 
Keputusan: 
155 rekod pesakit yang memenuhi syarat-syarat kajian telah dianalisa. Usia 
min pesakit adalah 62 ± 17 tahun. Kadar kematian akibat jangkitan paru-paru 
perolehan komuniti adalah 19.4°k. Faktor-faktor yang mempengaruhi kadar 
kematian ialah komposisi komorbid utama (OR11.1; p=0.001 ), kekeliruan (OR 
18.7;p=0.001) dan hipoksemia (OR 10.6;p=0.002). Faktor lain yang dikenal 
pasti adalah tekanan darah diastoli yang rendah dan hiperglisemia ~ 13 
mmol/1 dengan kebarangkalian(OR)1.1 (p=0.002)dan 6.4(p=0.007). 
Pesakit mempunyai risiko kematian setinggi 46.3 kali ganda sekiranya 
terdapat tiga daripada faktor-faktor berikut; mempunyai komposisi komorbid 
utama, kekeliruan, tekanan darah diastoli rendah, hipoksemia dan 
hiperglisemia. Analisa terhadap kriteria keterukan telah mengenalpasti 21 
daripada 27 pesakit dalam kajian ini mengalami jangkitan paru-paru yang 
serius. Sensitiviti kriteria yang dicadangkan untuk meramal tahap keterukan 
penyakit adalah 0. 70 dan tahap penilaian negatif 0.93. 
Rumusan: 
Kadar kematian akibat jangkitan paru-paru perolehan komuniti di HUSM 
adalah setara dengan kajian yang lampau. Faktor yang boleh mempengaruhi 
xii 
kadar kematian ini juga adalah hampir sama. Sebitangan daripada faktor-
faktor ini dapat digunakan untuk menentukan tahap keterukan penyakit 
jangkitan paru-paru. Kehadiran tiga daripada factor ini dapat membantu 
mengenal pasti sebilangan pesakit yang berisiko tinggi, seterusnya 
perawatan yang optimum dapat diberikan. 
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ABSTRACT 
The outcome of hospitalized patients with Community- Acquired 
Pneumonia in HUSM. 
Background: 
Community-acquired pneumonia (CAP) remains an important cause of hospital 
admission. Studies have shown that the mortality of patients admitted with 
community-acquired pneumonia is high. The outcomes have been shown to be 
influenced by various clinical variables at presentation. Applications of these 
variables as predictor of severity have been shown to improve patients 
management outcome. The outcome of patients admitted due to CAP has not 
been studied in Hospital University Science Malaysia (HUSM). The main purpose 
of this study was to evaluate outcome in patients who required admission due to 
community acquired pneumonia in HUSM and to determine factors that 
influenced their poor outcome. 
Methodology: 
This was a retrospective cohort study between January 2004 to December 2004. 
Records of patients with community-acquired pneumonia admitted to HUSM 
were screened. This study included all patients aged more than 12 years old who 
met the inclusion criteria. The following information; demographic data, initial 
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clinical findings, laboratory investigations and type of antibiotics regime given 
were recorded into customized data collection sheet. Variables obtained were 
examined for association with mortality. Severity prediction criteria were 
formulated from identified variables that showed significant association with 
mortality. 
Results: 
Records of 155 patients' that met the inclusion criteria were evaluated. The mean 
age at presentation was 62 ± 17 years. The mortality rate was 19.4%. Variables 
that significantly influenced the mortality on multivariate analysis at presentation 
were presence of important co-morbid illnesses (OR 11.13; p = 0.001 ), confusion 
(OR 18.72; p = 0.001) and hypoxaemia (OR 10.62; p = 0.002). Other factors 
identified were low diastolic blood pressure and random blood sugar greater than 
13 mmol/1 with odds ratio of 1.08 (p=0.002) and 6.37 (p=0.007) respectively. 
The presence of any three of following variables on admission; presence of co-
morbid illness, confusion, low diastolic blood pressure of s 60 mmHg, low oxygen 
saturation and random blood sugar equal or greater than 13 mmol/1 was 
associated with a 46.3 fold increase in death. 
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The suggested predictive severity rule identified 21 of the 27 patients who died 
as having severe community acquired pneumonia. The sensitivity of the 
suggested severity model for predicting death was 0. 70 and specificity of 0.95. 
The rule had a negative predictive value of 0.93. 
Conclusion: 
The mortality from community-acquired pneumonia requiring hospitalization in 
our centre is high compared to previous studies. We found that certain factors 
that influenced the outcome of our patients were almost similar with other 
previous studies. We found that the presences of three of the five variables (co-
morbid illness, confusion, low diastolic blood pressure, hypoxaemia and 
hyperglycaemia) would allow us to detect patients who at risk of poor outcome. 
xvi 
STUDY BACKGROUND 
Community-acquired pneumonia is a major health concern throughout the 
world as it has high morbidity and mortality. This inevitably leads to increase 
in health care cost and economic burden. It is estimated that USD 400 million 
is spent for the management of these patients. Each year in the United 
States, an estimated 4 million cases occur. Most patients are managed in the 
community whereas admission to hospital is required in 20 to 40% of patients. 
(Hoare and Lim, 2006). 
A systematic review of the literature on pneumonia prognosis has identified a 
variety of demographic factors, symptoms, physical examination findings, co-
morbid illnesses, laboratory abnormalities, and aetiologic agents that are 
independently associated with mortality in patients who required 
hospitalization. By combining these prognostic factors, investigators have 
developed a variety of indices to predict short-term mortality. These predictive 
instruments vary with respect to the patient populations studied, number of 
predictor variables included and statistical methods used. 
There is not much data on mortality associated with community-aquired 
pneumonia in Malaysia. This study is to look at the outcome of patients who 
required hospitalization for pneumonia in Hospital University Science 
Malaysia (HUSM) and to study the factors associated with mortality. We hope 
that the data collected in this study would benefit physician managing these 
cases in this region. 
1 
INTRODUCTION 
1.1 OVERVIEW OF PNEUMONIA 
1.1.1 Definition 
Pneumonia is generally defined as inflammation of lung parenchyma 
characterized by consolidation of the affected area. In this condition the 
alveolar spaces being filled with exudates, inflammatory cells and fibrin. 
Distribution may be lobar, segmental or lobular. It can be defined 
pathologically as lobar pneumonia or bronchopneumonia. It can also be 
defined clinically as community acquired, hospital-acquired pneumonia and 
ventilator -associated pneumonia. 
Community-acquired pneumonia is defined as an acute infection of the 
pulmonary parenchyma in a patient who has acquired the infection in the 
community. Patients usually present with symptoms and signs consistent with 
an acute lower respiratory tract infection, with at least one systemic feature 
i.e. either a symptom complex of sweating, fever, rigor and/or temperature of 
38°C or more (MacFarlane et al, 2001 ). 
Hospital-acquired pneumonia is defined as infection of lung parenchyma 
occurring more than 48 hours after hospitalization. Where pneumonia occurs 
in the subset of patients receiving mechanical ventilation, it is termed as 
ventilator-associated pneumonia. 
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1.1.2 Pathogenesis 
Micro-organisms are deposited in terminal bronchioles and alveolar spaces 
via several mechanisms. These include aspiration of oropharyngeal or gastric 
contents, inhalation of bacterial laden aerosols and haematogenous spread 
from a distant infected site to the lung. Most of cases are due to aspiration 
and inhalation mechanism (Leeper and Moss, 2003). 
lnhalational entry of organism is associated with specific pathogens that are 
able to reach the lower airway. These pathogens include Legionella species, 
Mycoplasma pneumoniae, Chlamydia species and Coxiella bumetti. These 
pathogens share common ability to resist phagocytosis or to survive 
intracellularly within phagocytes. 
Depending on the balance between the virulence of the pathogen and the 
patient's host defense system, an intense inflammatory process ensues after 
propagation of organisms in the lower respiratory tract system. Exudation of 
protein-rich fluid in alveolar spaces then cause ventilation perfusion mismatch; 
contributing to increased work of breathing and hypoxia (Leeper and Moss, 
2003). 
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1.1.3 Incidence 
It is difficult to determine the true incidence of community acquired pneumonia 
(CAP) in a given population because it may range from mild infection which 
goes unreported by the patient to severe illness requiring hospitalization. The 
incidence might be under reported in less developed countries. It is estimated 
that up to 5.6 million cases of CAP occur annually in United States and as 
many as 1.1 million of these cases require hospitalization (Ramirez, JA 2003). 
Incidence of community-acquired pneumonia (CAP) also varies according to 
age group and study centers. Hoare and Lim (2006) reported that the annual 
incidence rate was 6 per 1 000 in the 18 to 39 age group. This incidence rose 
to 34 per 1000 population in those aged more than 75 years old. The 
incidence was similar in a study done by Jokinen and colleague, where the 
frequency of CAP occurred in the elderly age group was 34 per 1 000 
population (Jokinen et al, 1993). 
Based on three prospective population studies from United Kingdom, Finland 
and North America, the annual incidence of CAP ranges between 5 and 11 
per 1000 adult population (BTS, 2001 ). A Recent prospective observational 
study by O'Meara et al (2005) showed the incidence of hospitalization for 
pneumonia was 11.1 per 1000 person per year following median of 10.7 years 
follow up study. In 1997, based on the Malaysian second national health 
survey, Malaysia had a total of 19,827 reported hospital admissions due to 
pneumonia with 12.4% mortality. 
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1.1.4 Aetiology of Community Acquired Pneumonia 
The reported prevalence of specific pathogens varies depending on the 
methods by which the aetiological diagnoses were determined and the patient 
population studied. In most cases, there was a small range of key pathogens 
that were associated with community-acquired pneumonia. Most literature in 
western studies found Streptococcus pneumoniae as the most frequently 
identified pathogen (Farber 1999; BTS 2001; ATS 2001; Apisanithar and 
Murdy 2005). Other key pathogens reported were Haemophilus influenzae, 
Mycoplasma pneumonia, Legionella pneumophilia and Chlamydia 
pneumoniae (Ruiz, Ewig, Marcos et al 1999; Waltanathum, Chaoprasong, 
Nunthapisud et al 2003). 
In the local setting, a study by Liam et al (2001) at University Malaya Medical 
Center Kuala Lumpur showed the most frequent isolated pathogens were 
gram-negative bacilli. Klebsiella pneumoniae was the most frequently isolated 
which caused 1 0.2°/o of all cases, followed by Streptococcus pneumoniae and 
Haemophilus influenzae in 5.5°k cases, Mycoplasma pneumoniae and 
Pseudomonas aeruginosa (3.9°/o) were isolated in 3.9°/o cases respectively. 
A great deal of atypical pathogens causing CAP has been studied. Ngeow YF 
et al found that the overall infection rate for atypical pathogens in Asia-pacific 
region was 19.9% (Ngeow YF, 2001). This study which involved Malaysia 
(Kuala Lumpur and Petaling Jaya), found the infection rates for Mycoplasma 
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pneumoniae was 9.4%. While the infection rate for Legionel/a pneumophilia 
and Chlamydia pneumoniae was 6.2% and 4.3% respectively. 
Burkholderia pseudoma/lei should be considered as one of the causative 
organism in community-acquired pneumonia in Southeast Asia especially in 
patients with diabetes mellitus. In Northeastern Thailand, Burkholderia 
pseudomal/ei were identified in 11% of patients hospitalized for CAP 
(Reechaipichitkul and Tantiwong, 2002). 
In a study conducted in Malaysia, Burkholderia pseudomal/ei was identified 
as the causative microorganism for CAP in 1.6% of cases (Liam et al, 2001 ). 
Whereas in a recent study by How and colleague conducted in Pahang over 
three years, 40°A» of confirmed cases of meliodosis presented with pneumonia 
(How et al 2005). 
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1.1.5 Risk factors for pneumonia 
1.1.5(a) Age 
Community-acquired pneumonia (CAP) is a frequent cause of hospital 
admission and has significant morbidity and mortality in the elderly. The 
important effect of age on symptoms and clinical presentation of pneumonia 
were first described by Sir Wiliam Osler many years ago (Feldman 1999). 
Many studies had shown an increased incidence and fatality rate in the 
elderly. The cardinal risk factors for high incidence of pneumonia in elderly are 
presence of co-morbidity and malnutrition (Schafer H. and Ewig S. 2000). 
The incidence of community acquired pneumonia in persons 65 years or older 
ranged between 51.1 and 55.6 per 1000 persons per year (Feldman, 1999). 
The incidence of hospitalized elderly patients with community-acquired 
pneumonia also rose to five-fold as age increases from 65-69 to more than 90 
years (Kaplan, Angus, Griffin, et al 2002). 
There is no simple explanation for the increased susceptibility of the elderly to 
pneumonia. Many age related changes are thought to increase the risk. 
These include systemic disease such as diabetes, lung disease, cardiac 
disease or rheumatism in addition to various age-associated changes in lung 
structure and function accompanied by age associated alterations in the 
immune system. 
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There is a change in subpopulations of T lymphocytes in the circulation with 
increase in percentage of immature cells in the elderly. T lymphocytes in 
elderly patients have an attenuated mitogenic response to antigen and a 
reduced capacity to produce or respond to cytokines such as interleukin-2 
(Feldman 1999). 
The elderly have been shown to have an increase in oropharyngeal 
colonization rate with pathogens such as Staphylococcus aureus and aerobic 
gram-negative bacilli such as Klebsiella pneumonia and Escherichia coli 
(Feldman 1999). A study by Liam et al (2001 ), had confirmed that gram-
negative bacilli were more frequently identified in patients age 60 yea~s or 
older. 
Although this colonization may be transient, it may increase the risk of 
pneumonia caused by these pathogens. Colonization occurred particularly in 
patients who are unable to ambulate without assistance, who have difficulty 
performing their daily activity of living, who have bladder incontinence, chronic 
cardiac or respiratory disease. 
1.1.5(b) Alcoholism 
High alcohol intake is the main risk factor for developing pneumonia in middle-
aged people. Ethanol adversely affects many properties of the respiratory 
tract defense mechanism. Alcohol directly inhibits the ability of lung immune 
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cells to kill bacteria and excessive ethanol ingestion suppresses the normally 
protective acute inflammatory response to infection, resulting in defective 
recruitment of additional innate immune cells. 
Additionally it disrupts the link between innate and adaptive pulmonary 
immunity further hindering the alcoholic patient's ability to eliminate invading 
pathogens (Happel and Nelson 2004). Alcohol facilitates bacterial colonization 
of the oropharynx with gram-negative bacilli, impairs cough reflexes, alters 
swallowing and mucociliary transport and impairs the function of lymphocytes, 
neutrophils, monocytes and alveolar macrophages. Each of these factors 
contributes to the reduced bacterial clearance from the airways found in these 
patients. 
Infections caused by gram-negative bacilli and Legionella pneumophilia occur 
more frequently in heavy drinkers. Study by J.F. Sola et al (1995) found that 
high alcohol intake was an independent risk factor for developing community-
acquired pneumonia. They also found that patients with chronic alcoholism 
had a higher incidence of pneumonia caused by gram-negative bacilli and 
Staphylococcus aureus. 
Tumor necrosis factor-a. (TNF-a.) is one of the important cytokines produced 
by alveolar macrophages in pulmonary host defense against most key 
pathogens in community-acquired pneumonia. Alcohol intoxication has been 
shown to impair the pulmonary TNF-a. response to bacterial endotoxin 
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lipopolysaccharide (cell wall component of bacteria) produced by these 
pathogens (Happel and Nelson 2005). 
Acute ethanol exposure meanwhile prevents cleavage of TNF-a. from the 
producing cells surface rendering it further ineffective. However acoholism is 
not a risk factor for the pneumonia severity except in the case of 
pneumococcal infection with leucopenia. 
1.1.5(c) Smoking 
Smoking alters mucociliary transport and function that may lead to impaired 
clearance of aspirated particles from lower respiratory tract. Smoking also 
affects humoral and cellular host defenses, epithelial cell function and 
increases the adhesion of Streptococus pneumoniae and Hemophilus 
inf/uenzae to the oropharyngeal epithelium. Smoking also predisposes to 
infections by influenzae, Legionella pneumophi/ia and Streptococcus 
pneumoniae (Rabbat and Huchon 2004). 
1.1.5(d) Associated Disease 
Associated diseases or co-morbid illnesses are frequent in patients 
hospitalized due to community-acquired pneumonia, ranging from 46°/o to 
80% (Rabbat and Huchon 2004). Although associated diseases do not 
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increase mortality, in most studies up to 70% of fatal cases due to pneumonia 
had comorbid illness compared to 40% among those who survived (Rabbat 
and Huchon 2004). 
O'Meara in their study found that the risk for pneumonia was higher in 
patients with history of cardiovascular disease and chronic obstructive 
pulmonary disease (O'Meara et al, 2005). 
1.1.5(e) Miscellaneous factors 
Previous hospital stay increases the risk for pneumonia due to Streptococcus 
pneumoniae in particular. Exposure to stagnant water or to domestic water 
supply systems (Rabbat and Huchon 2004) may favor the development of 
legionnaires' disease. 
A variety of medications may contribute to the development of pneumonia 
especially in elderly patients, morphine and atropine interfere with mucociliary 
clearance; sedatives alter the coughing reflex and epiglottic function whereas 
corticosteroids and salicylates act on phagocytosis functions (Rabbat and 
Huchon 2004). Infection with Legionella species may be more frequent in 
patient on oral steroids (BTS 2001 ). 
II 
1.1.6 Diagnostic Testing for Community-Acquired· Pneumonia 
1.1.6(a) Noninvasive Testing 
The causative agent of community-acquired pneumonia can be identified by 
noninvasive microbiological investigation in majority of cases. In most 
instances, the causative agents were isolated from blood or expectorated 
sputum. 
1.1.6(a) i Sputum Gram Stain 
The gram stain of expectorated sputum has been widely used for the 
diagnosis of community-acquired pneumonia. The sputum gram stain can 
provide specific diagnostic information and serve as an early guide to therapy. 
However the use of sputum gram stains as a diagnostic tool can be 
misleading, as it needs to be interpreted according to strict criteria. A 
specimen with fewer than 1 0 squamous epithelial cells and more than 25 
neutrophils per low power field with evidence of a predominant bacteria 
morphotype examined under high power field is an accurate indicator of the 
cause of pneumonia. 
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1.1.6(a) ii Blood Culture 
Blood cultures are positive in 4% to 18% in hospitalized patients with 
community-acquired pneumonia (S.J. Skerrett 1999). The yield of blood 
culture is strongly influenced by prior antibiotic therapy. Blood cultures are 
positive in less than 5°/o of patients who have received prior antibiotics before 
the blood specimen is drawn. 
1.1.6(a) iii Antigen Detection 
Methods for the detection of microbial antigens in respiratory secretions or 
other body fluids can be used for rapid aetiologic diagnosis of community-
acquired pneumonia. Commonly used test can detect antigens for 
Streptococcus pneumoniae, Legionella pneumophilia and respiratory viruses. 
The specificity of these tests are generally more than 90°/o whereas the 
sensitivity are varies (table 1). 
Organism Specimen Sensitivity(0/o) Specificity(0/o) 
Streptococcus pneumoniae Sputum 42-90 73-1 00 
Serum 9-62 >90 
Urine 0-58 >90 
Legionella pneumophilia Sputum, BALF 22-75 >90 
Urine 55-90 >95 
Respiratory viruses Throat swab 50-90 >90 
BALF 50-90 >90 
Table 1: Antigen detection for diagnosis of community-acquired pneumonia. 
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1.1.6(a) iv Serological Antibody detection 
The serological measurement of a specific antibody response has limited 
value in establishing the aetiology of community-acquired pneumonia. The 
main reason is the lag of time response for a positive result, which may be up 
to several weeks. However, the detection of increased levels of specific 
immunoglobulin M antibody in a single serum sample can be use in the early 
diagnosis of pneumonia caused by Mycoplasma pneumoniae, Chlamydia 
pneumoniae, Legionella pneumophilia and Coxiella burnetti (Skerrette 1999). 
These tests, however, are less sensitive and specific if there was less than 
four-fold increase in antibody titers between paired serum specimens taken 
several weeks apart. 
1.1.6(b) Invasive Procedures 
Invasive procedures are rarely required for early microbiological investigation 
in community-acquired pneumonia except for thoracocentesis. 
Thoracocentesis is an important step in evaluation of pleural effusion 
associated with pneumonia (parapneumonic effusion). However, other 
invasive procedures can be very useful in cases of severe pneumonia and 
when there is suspicion of resistant pathogen. 
The yield of bacterial cultures obtained via invasive procedures varies 
according to the type of procedures (table 2). For most of these procedures, 
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the diagnostic yield can be augmented by testing for microbial antigens or 
nucleic acids. 
Procedure Sensitivity(%) Specificity(%) 
Thoracocentesis 5-56 >95 
Transtracheal aspirate 44-95 68-100 
Transthoracic aspirate 33-80 >95 
Bronchoscopy 
PSB ~ 1 03 CFU/ml 54-85 ~85 
BAL ~ 104 CFU/ml 38-58 ~85 
Table 2: yield of bacterial cultures from invasive procedure 
1.1.7 Impact on health system 
From prevalence base burden of illness study in United Kingdom estimated 
that CAP caused a direct health care cost of 441 million pounds annually 
during the 1992 to 1993 study period (Guest JF and Morris A, 1997). The 
average cost for managing pneumonia in the out patient community was 
estimated at 100 pounds per episode and those required hospitalization 
accounted for 87% of the total annual cost. 
The economic impact of the illness reported in the United States was 
estimated to be 8.4 billion USD in direct costs; 400 million USD was spent on 
the care of 4.5 million outpatients while 8 million USD was spent on the care 
of 1. 1 million hospitalized patients with community-acquired pneumonia 
(Niederman et al, 2001 ). 
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Increase health care utilizations have been shown to be due to improper used 
of antibiotic hence lead to antibiotic resistance and failure 0f'Ju et al, 2004 ). A 
study by Wu found increase in health care cost in patients with community-
acquired pneumonia who failed with initial macrolide treatment within four 
weeks of therapy. These patients had used more medical care services and 
received a second antibiotic within 4 weeks of initial macrolide therapy. 
Substantial saving in cost could probably be made by strategies to reduce the 
requirement for hospital admission and shorten the length of hospital stay for 
patients with non-severe community acquired pneumonia. 
1.1.8 Measures to reduce health burden 
Various treatment protocols were developed to guide management of patients 
with community-acquired pneumonia. Management concordant to the protocol 
will improve health care cost and socio-economic impact associated with this 
disease. Among the protocols developed were antibiotic prescribing protocol, 
pneumonia severity tools and management algorithm. 
AI-Eidan et al (2000) reported that by using a specific antimicrobial prescribing 
protocol, there was a significant reduction in length of hospital stay, duration 
of intravenous antibiotic and treatment failure. These changes were 
significantly associated with reduction in healthcare related cost. 
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A study by Brown et al (2003) assessed the impact of. initial antibiotic choices 
on total hospital cost and length of hospital stay. This hospital claim-made 
database study had confirmed the value of dual therapy in reducing mortality, 
total length of stay and hospital charges. 
Identifying patients with less severe or mild pneumonia will reduce 
unnecessary hospitalization and subsequently reduce healthcare cost. 
Applying disease specific prediction rules will help physicians in deciding 
whether a patient can be safely treated at outpatient setting. One of most 
widely used and validated prediction rules is the pneumonia severity index 
proposed by American Thoracic Society 2001 clinical guideline for the 
management of adults with community-acquired pneumonia (Niederman MS 
et al2001). 
By applying the algorithm, patients in low risk class i.e. risk class I, II and Ill 
are at low risk of death and can be safely treated as outpatients (Fine et al, 
1997). Orrick found patients treated with preferred antibacterial therapy as 
recommended by Infectious Disease Society Association (IDSA), had a 
shorter mean length of hospital stay, a lower total cost of hospitalization and 
lower antibacterial cost compared with patients who did not receive preferred 
therapy (Orrick JJ et a/2004). 
Variations in clinical practice have a major influence on cost of care, although 
there is no evidence that it changes the patient's outcome. Laing eta/ (2004) 
identified that variations in management of hospitalized CAP patients 
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outweighed the influence of patient's factors on the duration of intravenous 
antibiotic therapy. This variation, in turn was the major determinant for length 
of stay for hospitalized patients and has correlation with total health care cost. 
1.1.9 Pneumonia Vaccination 
Influenza vaccination is recommended for those at high risk of mortality from 
influenza or pneumonia complications. These high-risk groups include those 
with chronic lung disease, heart, renal and liver disease, patients with 
diabetes mellitus, those who are immunosuppressed due to disease or 
treatment and those patients aged over 65 years (BTS 2001) of age. 
Pneumococcal vaccination is recommended in all elderly person age 65 years 
or older (BTS guideline 2001; Gross 2001 ). Vaccination is also recommended 
in other patients who have risk for pneumococcal infection. These groups of 
patients include those who have severe dysfunction of the spleen e.g. patients 
with sickle cell disease and celiac disease or anatomic asplenia and those 
patient's with chronic illnesses (congestive heart failure, chronic obstructive 
pulmonary disease, diabetes mellitus, alcoholism and cirrhosis). A study by 
Fisman and colleagues showed prior vaccination against pneumococcus is 
associated with improved survival, decreased chance of respiratory failure 
and decreased length of hospital stay among patients with community-
acquired pneumonia (Fisman DN, Abrutyn E, Spaude KA et al 2006). 
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1.2 COMMUNITY-ACQUIRED PNEUMONIA MORTALITY 
1.2.1 Frequency 
The mortality from community-acquired pneumonia in patients treated as 
outpatients ranged from 1 °.4> to 5°/o. While for hospitalized patients the 
mortality rate ranged from 15% to 30%, making it the seventh leading cause 
of death in United States of America (Mokdad et al, 2000). Those requiring 
intensive care were found to have mortality as high as 50% (Gibson et al 
2003). A local study by Liam CK (2005) found that the overall in-hospital 
mortality in adult patients to be as high as 11%. 
1.3 RISK FACTOR FOR PNEUMONIA MORTALITY 
1.3.1 Age 
Respiratory tract infections are a major cause of disease and death in the 
elderly. In 1995, from weekly morbidity and mortality report in the United 
State, 89°/o of all pneumonia deaths were attributed to patients aged 65 years 
or more. There was an increment of 44°/o pneumonia deaths in this age group 
from 1975 to 1992. 
A Finnish study found that increasing age (for age more than 70 vs. 60-69 
years) is one of the independent risk factors for pneumonia related mortality 
(Koivula 1994). An epidemiological study by Feikin identified advanced age as 
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among factors associated with mortality together with· presence of underlying 
disease and Asian race (Feikin et a/2000). A study by Liam found a similar 
trend of mortality in elderly patients. He found mortality rate in patients aged 
more than 65 years old was as high as 53% (Liam CK 2005). 
Elderly individuals may be at increased risk of death due to progressively 
impaired immune-surveillance, depressed ability to mount an appropriate 
immune response or dysregulated immune responses (Meyer, KC 2001 ). 
Frequently, elderly patients had associated medical illnesses that can account 
for higher mortality in pneumonia. In patients with cardiac disease, the risk of 
death from community-acquired pneumonia is multiplied by 5-fold (Rabbat 
and Huchon 2004). Another study by O'Meara found that elderly patients with 
age more than 65 years old with co-existing chronic obstructive pulmonary 
disease had higher risk of death from pneumonia (O'Meara et al 2005). 
1.3.2 Pre-hospitalization Functional status 
Marrie and Wu in their study found that functional status at the time of 
admission was an independent predictor of mortality. Patients who were 
wheelchair bound or bedridden were more likely to die compared to patients 
who are able to walk unaided (Marie T J and Wu LL, 2005). 
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Similarly Salive et a/ also found limitations in activities of daily living and 
cognitive impairment was independently associated with a significantly 
increased risk of pneumonia mortality (Salive et a/, 1993). 
1.3.3 Markers of inflammatory response 
The usefulness of the inflammatory markers to assess the outcome of CAP is 
still unclear. The use of inflammatory markers may help to identify those 
patients with poor prognosis and may help to establish different therapeutic 
strategies. Multiples profiles of inflammatory markers have been studied. 
These include pro-inflammatory markers such as tumor necrosis factor alpha 
(TN F-a.), interleukin 1 J3 (IL-1 (3), IL-6, IL-8 and anti-inflammatory cytokine (IL-
10). 
Higher concentrations of pro-inflammatory and anti-inflammatory cytokines 
were found in Legionella pneumonia, in bacteremic pneumonia episodes, 
those patients who required mechanical ventilation and as well as in non-
survivors from severe pneumonia (Fernandez-Serrano et a/ 2003). In the 
study, Fernandez also found that serum IL-6 and IL-1 0 concentrations greater 
than 87 pg/ml and 14.7 pg/ml, respectively at 48 hours after admission, 
predicted a higher mortality rate. An increase in serum level of IL-6 between 
day 1 and day 3 signifies non-responders group of patients with severe CAP 
following empirical antibiotic therapy (lgonin et a/2004). 
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Procalcitonin (PCT) is a peptide consisting of 116 amino acids, and has been 
found to be elevated in patients with sepsis and severe infections. In a study 
of community-acquired pneumonia, PCT is elevated in infective cases with 
typical bacterial etiology rather than pneumonia caused by atypical organism 
(Hedlund 2000). 
Correlation of PCT with the clinical status of patients with pneumonia and 
prognosis of the disease has been studied by Brunkhorst and colleague 
(Brunkhorst et a/ 2002). In this study, they found that the determination of 
PCT has slight but limited prognostic value in patients with pneumonia. In the 
later course of the disease, they found that non-survivor groups showed 
higher levels of PCT (Brunkhorst et a/2002). 
1.3.4 Presence of Co-morbid illness 
Various clinical guidelines (CTS 2000, ATS 2001, BTS 2001 and I DSA 2003) 
addressed the importance of pre-existing co-morbidity on severity of 
community-acquired pneumonia and its association with in hospital mortality. 
A study in University Malaya Medical Center found that mortality from CAP 
was more likely in patients with co-morbid illness. Twelve of 13 patients who 
died from CAP had other co-morbid illnesses compared to 63 of 114 patients 
who survived (Liam 2001}. A more recent study by the same author found that 
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hospitalized patients due to CAP with co-existing congestive cardiac failure 
was independently associated with an increased mortality risk (Liam 2005). 
Other co-morbid illnesses that had been associated with increased risk of 
mortality in patients hospitalized due to CAP are cerebrovascular accident 
and co-existing infectious disease (O'Meara et al 2005 and Fine 2001 ), 
diabetes mellitus, neoplastic disease, history of liver disease and presence of 
renal impairment (Fine 2001 ). Increased risk of mortality in patients with 
underlying liver disease is due to increase likelihood of treatment failure 
among this group of patients (Menendez 2004). 
1.3.5 Physical and Laboratory findings 
Several studies in CAP found that classic constitutional symptoms such as 
fever may not be present especially in the elderly. Lack of fever on 
hospitalization may be related to poor systemic inflammatory response in the 
elderly. A few studies have shown that apyrexia was a statistically significant 
adverse prognostic factor. 
In a study of 359 patients with CAP, Fang eta/ (1990) found that mortality for 
febrile patients was 12% as compared with 31% for afebrile patients. Sunket 
eta/ (2004) reported in their prospective clinical study that mortality was 29°/o 
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in the group without fever compared to 4% in those with fever. They 
concluded that mortality rate in the afebrile group with leukocytosis was seven 
times higher than in the group with fever and leucocytosis. 
ATS (2001) CAP guideline reported that certain physical findings are 
associated with higher mortality or a more complicated course in patients 
hospitalized with pneumonia. These physical findings include respiratory rate 
more or equal than 30 breaths/min, diastolic blood pressure less than 60 mm 
Hg or systolic blood pressure less than 90 mm Hg, pulse rate more than 
125/min and fever less than 35°C or more than 40°C. However guideline from 
BTS (2001) reported only temperature less than 37°C and respiratory rate 
more than 24 breaths/min were predictors of unfavourable outcome for 
hospitalized patients with CAP. 
In a study by Marrie et a/ (2005) which involved 3043 patients, in which 246 
patients died (8.1 %), they found that hyperkalemia and lymphopenia were 
associated with early mortality (less than 5 days hospitalization). 
As respiratory failure is the leading cause of death among patients admitted 
with CAP, measurement of partial pressure arterial oxygenation (Pa02) and 
arterial carbon dioxide pressure (PaC02) is important in the initial evaluation 
of patients with CAP. Hypoxaemia has been associated with impending 
respiratory failure with subsequent intensive care unit admission and 
mortality. 
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